Published November 11, 2021
| Version v1
Patent
Open
COMPOSITION AND METHODS FOR TUMOR IMAGING AND TREATMENT
Contributors
Patent applicant:
Description
Radioisotope-labeled small molecule activity-based probes that target the cancer associated serine hydrolase neutral cholesterol ester hydrolase 1 (NCEH1) are described. The probes can undergo a reaction with the NCEH1, resulting in covalent bonding of a portion of the probe molecule to the NCEH1. Also described are methods of labeling NCEH1 in biological samples, such as cells or tissue, and methods of visualizing tumors using the radioisotope-labeled NCEH1 probes as tracer compounds, either alone or in combination with assessing the efficacy of a cancer treatment or potential cancer treatment.
Files
US20210346525.pdf
Files
(4.9 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:84b3f875347adc7517b74ce616ad854f
|
4.9 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 202117317529 A
- Patent number
- US 2021/0346525 A1
- Other
- oai:uchicago.tind.io:9178
Dates
- Patent filed
-
2021-05-11